ACTA1 and acute myeloid leukemia: Importantly, the pathological diagnosis of AML requires co‐expression of melanocytic (e.g., HMB‐45) and muscle‐related markers [e.g., αSMA (α smooth muscle actin)] (Folpe & Kwiatkowski, 2010).